2013 Q4 Form 10-Q Financial Statement

#000119312513427929 Filed on November 05, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q3
Revenue $45.00K $38.00K $264.0K
YoY Change -78.67% -85.61% 20.0%
Cost Of Revenue $86.00K $85.74K $72.00K
YoY Change 56.36% 19.09% 20.0%
Gross Profit -$41.00K $239.0K $192.1K
YoY Change -126.28% 24.44% 20.07%
Gross Profit Margin -91.11% 629.08% 72.77%
Selling, General & Admin $3.650M $1.711M $1.636M
YoY Change 72.99% 4.54% -5.41%
% of Gross Profit 715.65% 851.85%
Research & Development $4.820M $5.184M $3.478M
YoY Change 2.99% 49.06% -23.05%
% of Gross Profit 2168.75% 1810.55%
Depreciation & Amortization $330.0K $260.0K $240.0K
YoY Change 43.48% 8.33% -22.58%
% of Gross Profit 108.76% 124.93%
Operating Expenses $9.341M $6.628M $5.269M
YoY Change 34.42% 25.79% -15.83%
Operating Profit -$9.382M -$6.656M -$5.077M
YoY Change 38.11% 31.1% -16.77%
Interest Expense $2.450M $382.1K $11.39K
YoY Change -39.21% 3254.27% -99.32%
% of Operating Profit
Other Income/Expense, Net $2.508M -$535.6K -$11.26M
YoY Change -37.83% -95.24% -8142.55%
Pretax Income -$6.510M -$7.190M -$16.34M
YoY Change 135.87% -56.0% 277.37%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.962M -$7.192M -$16.34M
YoY Change 152.43% -55.98% 277.3%
Net Earnings / Revenue -15471.11% -18925.4% -6188.26%
Basic Earnings Per Share
Diluted Earnings Per Share -$232.0M -$239.7M -$817.0M
COMMON SHARES
Basic Shares Outstanding 54.97M shares 41.30M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.59M $20.96M $21.74M
YoY Change 36.75% -3.59% 73.5%
Cash & Equivalents $30.59M $20.96M $15.71M
Short-Term Investments $0.00 $0.00 $6.030M
Other Short-Term Assets $83.54K $110.6K $1.180M
YoY Change -89.82% -90.63% 140.82%
Inventory
Prepaid Expenses $530.0K $464.5K
Receivables $108.8K $125.5K $100.0K
Other Receivables $490.0K $490.0K $220.0K
Total Short-Term Assets $31.84M $22.20M $23.24M
YoY Change 32.44% -4.48% 70.63%
LONG-TERM ASSETS
Property, Plant & Equipment $5.305M $5.439M $1.540M
YoY Change 285.7% 253.16% -31.56%
Goodwill $2.139M $1.973M
YoY Change 7.86%
Intangibles $1.836M $1.673M
YoY Change 0.7%
Long-Term Investments
YoY Change
Other Assets $413.7K $999.8K $1.030M
YoY Change -56.33% -2.93% -46.07%
Total Long-Term Assets $9.717M $10.12M $6.420M
YoY Change 58.54% 57.59% -27.38%
TOTAL ASSETS
Total Short-Term Assets $31.84M $22.20M $23.24M
Total Long-Term Assets $9.717M $10.12M $6.420M
Total Assets $41.56M $32.32M $29.66M
YoY Change 37.74% 8.96% 32.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.152M $1.861M $960.0K
YoY Change 15.26% 93.81% -32.39%
Accrued Expenses $4.068M $2.304M $2.830M
YoY Change 50.25% -18.6% -24.53%
Deferred Revenue
YoY Change
Short-Term Debt $3.660M $3.600M $0.00
YoY Change
Long-Term Debt Due $125.0K $178.8K $210.0K
YoY Change -39.39% -14.88% -8.7%
Total Short-Term Liabilities $9.132M $8.062M $4.050M
YoY Change 79.16% 99.07% -25.96%
LONG-TERM LIABILITIES
Long-Term Debt $9.270M $9.900M $190.0K
YoY Change 7316.0% 5110.53% -48.65%
Other Long-Term Liabilities $8.200M $10.79M $16.19M
YoY Change -25.11% -33.35% 510.94%
Total Long-Term Liabilities $17.47M $20.69M $16.38M
YoY Change 13876.0% 26.31% 442.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.132M $8.062M $4.050M
Total Long-Term Liabilities $17.47M $20.69M $16.38M
Total Liabilities $26.60M $28.76M $20.43M
YoY Change 64.36% 40.75% 140.92%
SHAREHOLDERS EQUITY
Retained Earnings -$387.5M -$380.6M
YoY Change 7.32%
Common Stock $402.2M $384.0M
YoY Change 7.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.95M $3.561M $9.220M
YoY Change
Total Liabilities & Shareholders Equity $41.56M $32.32M $29.66M
YoY Change 37.74% 8.96% 32.06%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q3
OPERATING ACTIVITIES
Net Income -$6.962M -$7.192M -$16.34M
YoY Change 152.43% -55.98% 277.3%
Depreciation, Depletion And Amortization $330.0K $260.0K $240.0K
YoY Change 43.48% 8.33% -22.58%
Cash From Operating Activities -$6.890M -$6.000M -$4.230M
YoY Change 40.04% 41.84% 13.71%
INVESTING ACTIVITIES
Capital Expenditures -$120.0K -$2.140M $0.00
YoY Change 140.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$120.0K $1.430M -$4.330M
YoY Change -98.48% -133.03% -211.89%
Cash From Investing Activities -$240.0K -$710.0K -$4.340M
YoY Change -96.97% -83.64% -218.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 16.77M 4.910M 17.08M
YoY Change 198.93% -71.25% 1933.33%
NET CHANGE
Cash From Operating Activities -6.890M -6.000M -4.230M
Cash From Investing Activities -240.0K -710.0K -4.340M
Cash From Financing Activities 16.77M 4.910M 17.08M
Net Change In Cash 9.640M -1.800M 8.510M
YoY Change -233.33% -121.15% 991.03%
FREE CASH FLOW
Cash From Operating Activities -$6.890M -$6.000M -$4.230M
Capital Expenditures -$120.0K -$2.140M $0.00
Free Cash Flow -$6.770M -$3.860M -$4.230M
YoY Change 39.01% -8.75% 20.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.00
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54971174 shares
CY2009Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
5135000
CY2009Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
36000
CY2009Q1 stem Business Acquisition Cost Of Acquired Entity Purchase Price Net
BusinessAcquisitionCostOfAcquiredEntityPurchasePriceNet
5135000
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15712688
CY2013Q1 us-gaap Restructuring Reserve
RestructuringReserve
505000
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.85
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
440126 shares
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-35090
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42044839 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42044839 shares
CY2013Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
19.90
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
431558 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9601378 shares
CY2013Q3 us-gaap Shares Issued
SharesIssued
329131 shares
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Loans Payable Current
LoansPayableCurrent
3602972
CY2013Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2303506
CY2013Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
20936
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1860544
CY2013Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
9865375
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8062346
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
170605
CY2013Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
34896
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
3560892
CY2013Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
383537795
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-380567957
CY2013Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
67588
CY2013Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
654961
CY2013Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1987496
CY2013Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1792683
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
420449
CY2013Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
28050
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32316582
CY2013Q3 us-gaap Liabilities
Liabilities
28755690
CY2013Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
67116
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
178750
CY2013Q3 us-gaap Assets Current
AssetsCurrent
22199223
CY2013Q3 us-gaap Goodwill
Goodwill
1973302
CY2013Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
20955293
CY2013Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1673051
CY2013Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
999776
CY2013Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
464464
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
289000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
247000
CY2013Q3 us-gaap Assets
Assets
32316582
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20955293
CY2013Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
125487
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
275000
CY2013Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
51808
CY2013Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100000
CY2013Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3939612
CY2013Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
32571
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
110615
CY2013Q3 us-gaap Other Receivables
OtherReceivables
491556
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
275000
CY2013Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
267000
CY2013Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4767000
CY2013Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
20955293
CY2013Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5438659
CY2013Q3 stem Carrying Value Of Purchased Loans
CarryingValueOfPurchasedLoans
9512000
CY2013Q3 stem Fair Value Of Warrant Liability
FairValueOfWarrantLiability
8420954
CY2013Q3 stem Finite Lived Intangible Acquired Assets
FiniteLivedIntangibleAcquiredAssets
64000
CY2013Q3 stem Fair Value Allocated To Warrant
FairValueAllocatedToWarrant
388000
CY2013Q3 stem Deposits And Other Long Term Liabilities
DepositsAndOtherLongTermLiabilities
512320
CY2013Q3 stem Outstanding Principal Amount Of Long Term Debt
OutstandingPrincipalAmountOfLongTermDebt
179000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13311261
CY2011Q4 stem Impairments Of Intangible Asset Finite Lived
ImpairmentsOfIntangibleAssetFiniteLived
655000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37506305 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37506305 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2707441
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
6888
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
125000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
999365
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5097132
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
193177
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
12646
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
13984617
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
374507552
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-361091175
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
74426
CY2012Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1389342
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
375063
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30170277
CY2012Q4 us-gaap Liabilities
Liabilities
16185660
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
79736
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
206250
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13900678
CY2012Q4 us-gaap Assets Current
AssetsCurrent
24041317
CY2012Q4 us-gaap Goodwill
Goodwill
1983426
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
22373308
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1822904
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
947301
CY2012Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
537590
CY2012Q4 us-gaap Assets
Assets
30170277
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8471275
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
110159
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
820827
CY2012Q4 us-gaap Other Receivables
OtherReceivables
200788
CY2012Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
22371952
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1375329
CY2012Q4 stem Fair Value Of Warrant Liability
FairValueOfWarrantLiability
9265365
CY2012Q4 stem Deposits And Other Long Term Liabilities
DepositsAndOtherLongTermLiabilities
216439
CY2012Q4 stem Accrued Wind Down Expenses Current
AccruedWindDownExpensesCurrent
1102762
CY2012Q4 stem Outstanding Principal Amount Of Long Term Debt
OutstandingPrincipalAmountOfLongTermDebt
331000
CY2012Q4 stem Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
1356
dei Trading Symbol
TradingSymbol
STEM
dei Entity Registrant Name
EntityRegistrantName
STEMCELLS INC
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000883975
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Debt Instrument Term
DebtInstrumentTerm
P3Y
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39787527 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16432180
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y2M12D
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P12Y2M12D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13662749 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> <b>Use of Estimates</b></p> <p style="MARGIN-TOP: 6pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.</p> <p style="MARGIN-TOP: 12pt; TEXT-INDENT: 4%; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt"> Significant estimates include the following:</p> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="1%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the grant date fair value of stock-based awards recognized as compensation expense (see Note 5, &#x201C;Stock-Based Compensation&#x201D;);</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="1%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the fair value of warrants recorded as a liability (see Note 9, &#x201C;Warrant Liability&#x201D;); and</td> </tr> </table> <p style="MARGIN-TOP: 0pt; MARGIN-BOTTOM: 0pt; FONT-SIZE: 6pt"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="1%">&#xA0;</td> <td valign="top" width="2%" align="left">&#x2022;</td> <td valign="top" width="1%">&#xA0;</td> <td valign="top" align="left">the fair value of goodwill and other intangible assets (see Note 4, &#x201C;Goodwill and Other Intangible Assets&#x201D;).</td> </tr> </table> </div>
us-gaap Revenues
Revenues
890689
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-782745
us-gaap Gross Profit
GrossProfit
660532
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
43600
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19499354
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
527967
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
730916
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8475
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
342366
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-23928
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-57569
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-342305
us-gaap Net Income Loss
NetIncomeLoss
-19476782
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
7302
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
152500
us-gaap Investment Income Interest
InvestmentIncomeInterest
8772
us-gaap Stock Issued1
StockIssued1
600006
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
52474
us-gaap Operating Income Loss
OperatingIncomeLoss
-19134477
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
34946
us-gaap Interest Paid
InterestPaid
271054
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22572
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
100000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4556406
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
9900000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1356
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
499935
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-425570
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19634538
us-gaap Cost Of Goods Sold
CostOfGoodsSold
230157
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
13558358
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-19146
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
460097
us-gaap Share Based Compensation
ShareBasedCompensation
2033228
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-10124
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12486485
us-gaap Debt Issuance Costs
DebtIssuanceCosts
117000
us-gaap Interest Expense
InterestExpense
785122
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6115442
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
38500
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9284127
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14553145
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2809
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
730504
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
5000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2033228
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
14430000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1165000
us-gaap Operating Expenses
OperatingExpenses
19795009
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5180027
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2467
stem Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
431390
stem Loan Fees
LoanFees
1000000
stem Term Of Operating Lease
TermOfOperatingLease
P15Y
stem Cash And Cash Equivalents Maturity Period
CashAndCashEquivalentsMaturityPeriod
P90D
stem Increase Decrease In Accrued Interest And Other Receivables
IncreaseDecreaseInAccruedInterestAndOtherReceivables
364940
stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.05
stem Increase Decrease In Accrued Wind Down Expenses
IncreaseDecreaseInAccruedWindDownExpenses
1102762
stem Number Of Share Based Equity Incentive Plan
NumberOfShareBasedEquityIncentivePlan
2 Incentive_Plan
stem Finite Lived Intangible Assets Foreign Currency Translation
FiniteLivedIntangibleAssetsForeignCurrencyTranslation
-311896
stem Long Term Debt Bond Interest Rate
LongTermDebtBondInterestRate
0.095 pure
stem Sale Value Of Common Stock
SaleValueOfCommonStock
30000000
stem Debt Instrument Amortized Discount Percentage
DebtInstrumentAmortizedDiscountPercentage
0.090 pure
stem Amortization Of Debt Discount And Debt Issuance Costs
AmortizationOfDebtDiscountAndDebtIssuanceCosts
509069
stem Wind Down Expenses
WindDownExpenses
61837
stem Continuing Value Of Patent
ContinuingValueOfPatent
0
stem Maturity Period Of Long Term Debt
MaturityPeriodOfLongTermDebt
2014-08
stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
159773
stem Expiry Period Of Lease Term
ExpiryPeriodOfLeaseTerm
2013-06-30
stem Debt Instrument Period During Which Loan Is Subject To Interest Only Payments
DebtInstrumentPeriodDuringWhichLoanIsSubjectToInterestOnlyPayments
P6M
stem Debt Instrument Period During Which Loan Is Subject To Principal And Interest Payments
DebtInstrumentPeriodDuringWhichLoanIsSubjectToPrincipalAndInterestPayments
P30M
stem Agreement Termination Month And Year
AgreementTerminationMonthAndYear
2013-10
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
24753 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25992764 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14949810
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.99
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12680199 shares
us-gaap Revenues
Revenues
1156865
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-170667
us-gaap Gross Profit
GrossProfit
948738
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
21721
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-25603643
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8109933
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
685364
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25364
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
141250
us-gaap Investment Income Interest
InvestmentIncomeInterest
9393
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-32926
us-gaap Operating Income Loss
OperatingIncomeLoss
-15752765
us-gaap Interest Paid
InterestPaid
40114
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
59090
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
125854
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40584
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9979942
us-gaap Net Income Loss
NetIncomeLoss
-25732707
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
18521
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
129064
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19729
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3210
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1613123
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
9974685
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20131310
us-gaap Cost Of Goods Sold
CostOfGoodsSold
208127
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-665
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4153584
us-gaap Share Based Compensation
ShareBasedCompensation
2227145
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2413838
us-gaap Interest Expense
InterestExpense
40014
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16196587
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2767662
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11165599
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
759527
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2227145
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5362000
us-gaap Operating Expenses
OperatingExpenses
16701503
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5336105
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12411
stem Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
69997
stem Increase Decrease In Accrued Interest And Other Receivables
IncreaseDecreaseInAccruedInterestAndOtherReceivables
-19432
stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.09
stem Increase Decrease In Accrued Wind Down Expenses
IncreaseDecreaseInAccruedWindDownExpenses
817110
stem Wind Down Expenses
WindDownExpenses
199799
stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
471501
stem Stock Issued For Option Agreement
StockIssuedForOptionAgreement
50000
CY2006Q3 stem Number Of Patients Violate Claims
NumberOfPatientsViolateClaims
4 Claim
CY2013Q2 us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
505000
CY2013Q2 stem Additional Expense Recorded To Revise Estimated Reserve At Period End
AdditionalExpenseRecordedToReviseEstimatedReserveAtPeriodEnd
39000
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30168475 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2012Q3 us-gaap Revenues
Revenues
263995
CY2012Q3 us-gaap Gross Profit
GrossProfit
192104
CY2012Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-16237497
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
203256
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11087
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2372
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5077218
CY2012Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
98706
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11259572
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-16336790
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
99293
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
587
CY2012Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
11239465
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
71891
CY2012Q3 us-gaap Interest Expense
InterestExpense
11392
CY2012Q3 stem Wind Down Expenses
WindDownExpenses
154742
CY2012Q3 stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
60739
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
18.87
CY2013Q3 stem Number Of Restricted Unit Would Vest Over Vesting Period
NumberOfRestrictedUnitWouldVestOverVestingPeriod
50000 shares
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3478142
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
767153
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
5269322
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1636438
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41402717 shares
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2012Q3 stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.03
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.00
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2013Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
723 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7845 shares
CY2013Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
85743
CY2013Q3 us-gaap Interest Expense
InterestExpense
382119
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5184365
CY2013Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
597005
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
6895114
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1710749
CY2013Q3 us-gaap Revenues
Revenues
324792
CY2013Q3 us-gaap Gross Profit
GrossProfit
239049
CY2013Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6985958
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
271994
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10094
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
136
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6656065
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
206120
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-535588
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-7191653
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
205695
CY2013Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
205696
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-425
CY2013Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
143511
CY2013Q3 stem Restricted Stock Units Vested Description After Specified Period
RestrictedStockUnitsVestedDescriptionAfterSpecifiedPeriod
25 pure
CY2013Q3 stem Number Of Restricted Unit Vest Over Next Fiscal Year
NumberOfRestrictedUnitVestOverNextFiscalYear
10000 shares
CY2013Q3 stem Share Based Compensation Impact On Basic And Diluted Earnings Per Share
ShareBasedCompensationImpactOnBasicAndDilutedEarningsPerShare
0.01
CY2013Q3 stem Revenue From Licensing Agreements And Grants
RevenueFromLicensingAgreementsAndGrants
52798
CY2013Q3 stem Restricted Stock Unit Vest Description
RestrictedStockUnitVestDescription
50,000 of these restricted stock units will vest and convert into shares of our common stock over a four year period

Files In Submission

Name View Source Status
0001193125-13-427929-index-headers.html Edgar Link pending
0001193125-13-427929-index.html Edgar Link pending
0001193125-13-427929.txt Edgar Link pending
0001193125-13-427929-xbrl.zip Edgar Link pending
d616160d10q.htm Edgar Link pending
d616160dex101.htm Edgar Link pending
d616160dex311.htm Edgar Link pending
d616160dex312.htm Edgar Link pending
d616160dex321.htm Edgar Link pending
d616160dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g616160g09y75.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stem-20130930.xml Edgar Link completed
stem-20130930.xsd Edgar Link pending
stem-20130930_cal.xml Edgar Link unprocessable
stem-20130930_def.xml Edgar Link unprocessable
stem-20130930_lab.xml Edgar Link unprocessable
stem-20130930_pre.xml Edgar Link unprocessable